AMH and metabolic dysfunction-associated steatotic liver disease: Factor 2 (Liver, Lipid, and Ovarian Function) comprises SGOT (0.97), VLDL (0.65), and AMH (0.47), aligning with Group C’s elevated SGOT and VLDL, suggesting potential non-alcoholic fatty liver disease (NAFLD).